Belotero Volume: Natural Midface Volume, Now at Our Practice

Coming to our Midtown Manhattan practice October 2026

If your cheeks have lost some of their fullness over time, or you were simply born without much natural projection there, Belotero Volume is a new FDA-approved option designed specifically to restore that structure without looking overdone. It’s the newest addition to the Belotero® family of biomimetic hyaluronic acid (HA) fillers, and Dr. Jane Yoo will be among the first providers in New York City offering it.

What Belotero Volume Is Used For

Belotero Volume is FDA-approved for deep injection, placed beneath the skin and, in some areas, down at the level of the bone (supraperiosteal), to:

  • Replace lost volume in the midface
  • Correct contour irregularities or asymmetry in the cheek area

It’s approved for adults 22 and older, reflecting that facial bone and soft tissue are still maturing in the early twenties.

Why It’s Different: Biomimetic CPM Technology

Belotero Volume is built on Merz Aesthetics’ Cohesive Polydensified Matrix (CPM®) gel technology, the same science behind Belotero Balance, now engineered for deeper placement. Rather than a single uniform gel, CPM combines zones of higher and lower HA density within the same product. In practice, that means the filler can provide structural lift where you need support while still integrating smoothly into surrounding tissue and moving naturally with your facial expressions, rather than sitting as a rigid, separate layer under the skin.

For patients who want a cheek that looks restored, not augmented, this integration matters. It’s part of why Dr. Yoo, whose practice is built around natural-looking results rather than dramatic transformation, was interested in bringing this product in.

What to Expect

Consultation: Dr. Yoo evaluates your midface structure, bone support, and skin quality to determine whether volume loss, contour asymmetry, or both are contributing to what you’re seeing in the mirror , and whether Belotero Volume, a different filler, or a combination approach is the better fit.

Treatment: Belotero Volume is injected at a deep level in the cheek. Most patients complete treatment in well under an hour.

Recovery: As with any injectable, some temporary swelling, tenderness, or bruising at injection sites is normal and typically resolves within days.

Results: In clinical studies submitted to the FDA, the vast majority of patients treated with Belotero Volume were satisfied with their results for as long as 18 months — making it a longer-lasting option within the midface volumizing category.

Is Belotero Volume Right for You?

Belotero Volume tends to be a good fit for patients who:

  • Have noticed flattening or hollowing in the cheeks with age
  • Were never born with much natural cheek projection
  • Have midface asymmetry they’d like softened
  • Want volume that moves naturally with their expressions, rather than a fixed, “set” look

It may not be the right choice for everyone. A consultation with Dr. Yoo is the best way to find out.

Important Safety Information

Belotero Volume is intended for use by a licensed, trained healthcare provider. As with all HA dermal fillers, it should not be used in patients with bleeding disorders, a history of anaphylaxis or multiple severe allergies, or a known hypersensitivity to lidocaine or amide-type anesthetics. Injection into blood vessels can, in rare cases, lead to vascular occlusion, tissue damage, or vision changes. Common side effects include temporary swelling, redness, tenderness, firmness, and bruising at the injection site. This is not a complete list of risks, full prescribing information and Important Safety Information are available at www.BELOTERO.com.

Ready to Learn More?

Belotero Volume is expected to be available at our practice starting October 2026. If you’d like to find out whether it’s the right option for your midface concerns, schedule a consultation with Dr. Yoo.

[Book a Consultation →]

Individual results vary. This page is for educational purposes and is not a substitute for a one-on-one consultation.

author avatar
Dr. Jane Yoo Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York. Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech. Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.